STOCK TITAN

Mathieu B. Streiff (AHR) receives 2,594 restricted shares after board re-election

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Streiff Mathieu B. reported acquisition or exercise transactions in this Form 4 filing.

American Healthcare REIT, Inc. director Mathieu B. Streiff reported an equity compensation grant. Upon his re-election to the board on June 24, 2026, he received 2,594 shares of restricted common stock, which vest on June 24, 2027. Following this award, he holds 34,971 shares of common stock directly and 157,402 shares indirectly through The Streiff Family Trust UA DTD 03/26/2013.

Positive

  • None.

Negative

  • None.
Insider Streiff Mathieu B.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 2,594 $0.00 $0.00
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 34,971 shares (Direct); Common Stock — 157,402 shares (Indirect, By The Streiff Family Trust UA DTD 03/26/2013)
Footnotes (1)
  1. F1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.
Restricted stock grant 2,594 shares Granted June 24, 2026 upon board re-election
Grant price per share $0.0000 per share Restricted common stock award
Direct holdings after grant 34,971 shares Common stock directly owned after transaction
Indirect holdings 157,402 shares Held by The Streiff Family Trust UA DTD 03/26/2013
Vesting date June 24, 2027 Restricted common stock vesting date
restricted common stock financial
"the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
indirect ownership financial
""direct_or_indirect": "I","nature_of_ownership": "By The Streiff Family Trust UA DTD 03/26/2013""
The Streiff Family Trust UA DTD 03/26/2013 financial
""nature_of_ownership": "By The Streiff Family Trust UA DTD 03/26/2013""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did AHR director Mathieu B. Streiff report?

Mathieu B. Streiff reported receiving 2,594 shares of restricted common stock as an equity grant. The award was tied to his re-election as a director and reflects standard, non-cash board compensation.

When do Mathieu B. Streiff’s new AHR restricted shares vest?

The 2,594 restricted common shares granted to Mathieu B. Streiff vest on June 24, 2027. Vesting means the shares become fully earned and transferable, subject to any company policies still in effect.

How many AHR shares does Mathieu B. Streiff own after this Form 4?

After the reported grant, Mathieu B. Streiff holds 34,971 AHR common shares directly. He also has 157,402 shares reported as indirectly owned through The Streiff Family Trust UA DTD 03/26/2013.

Was cash paid for the 2,594 AHR shares granted to Mathieu B. Streiff?

No cash was paid for this grant; the 2,594 restricted common shares were issued at a reported price of $0.0000 per share. This indicates a compensation award rather than an open-market purchase.

What triggered the latest equity grant to AHR director Mathieu B. Streiff?

The equity grant was triggered by Mathieu B. Streiff’s re-election as a director on June 24, 2026. Upon re-election, he was awarded 2,594 restricted common shares that vest one year later.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Streiff Mathieu B.

(Last)(First)(Middle)
C/O AMERICAN HEALTHCARE REIT, INC.
18191 VON KARMAN AVE., STE. 300

(Street)
IRVINE CALIFORNIA 92612

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/24/2026A2,594(1)A$034,971D
Common Stock157,402IBy The Streiff Family Trust UA DTD 03/26/2013
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Upon his re-election as a director to the board of directors of the Issuer on June 24, 2026, the Reporting Person was granted 2,594 shares of restricted common stock on June 24, 2026. The reported shares of restricted common stock vest on June 24, 2027.
/s/ MATHIEU B. STREIFF06/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)